We recently compiled a list of the 10 Buzzing AI Health Stocks. In this article, we are going to take a look at where Abbott ...

is questioning Abbott Laboratories' business practices after ... shortage that is leaving Americans scrambling to find the product.

TD Cowen analyst Josh Jennings maintained a Buy rating on Abbott Laboratories (ABT – Research Report) today and set a price target of ...

Based in Abbott Park, Illinois, Abbott Laboratories (ABT) is a global healthcare company that develops a broad range of ...

In a federal tax court petition, Abbott rejects numerous "arbitrary, capricious and unreasonable" determinations the IRS made ...

Abbott Laboratories’ $33.4 million sanctions award imposed in a trademark infringement lawsuit survived Thursday as the ...

"Abbott Laboratories began its 125th year with approximately ... "For our shareholders, we are developing the kind of essential, life-enhancing products that will ensure the enduring growth ...

Abbott Laboratories' diabetes care segment recently added new products to its lineup. It should remain one of the company's key growth drivers over the long run. There are other good reasons to ...

Abbott Laboratories closed $9.00 below its 52-week high ($121.64), which the company reached on March 8th.

Abbott Laboratories is a healthcare giant with products that span an array of therapeutic areas, from nutrition and diagnostics to cardiovascular health and diabetes care. Some of the company's ...

Patrick Wood has given his Hold rating due to a combination of factors that include the overall user experience and market considerations for Abbott Laboratories’ new product, Lingo. The device ...